Abstract
The neuronal ceroid-lipofuscinoses (NCL) are the most common group of progressive neurodegenerative diseases in children, with an incidence as high as one in 12,500 live births. The main features of this disease are failure of psychomotor development, impaired vision, seizures, and premature death. Many biochemical and physiological studies have been initiated to determine the cellular defect underlying the disease, although only a few traits have been truly associated with the disorders. One of the paradox’s of the NCL-diseases is the characteristic accumulation of autofluorescent hydrophobic material in the lysosomes of neurons and other cell types. However, the accumulation of this lysosomal storage material, which no doubt contributes to the neurologic disease, does not apparently lead to disease outside the CNS, and how these cellular alterations relate to the neurodegeneration in NCLs is unknown. Mutations have been identified in six distinct genes/proteins, namely CLN1, which encodes PPT1, a protein thiolesterase; CLN2, which encodes TPP1, a serine protease; and CLN3, CLN5, CLN6, and CLN8, which encode novel transmembrane proteins. Mutation in any one of these CLN-proteins results in a distinct type of NCL-disease. However, there are many shared similarities in the pathology of these diseases. The most obvious connection between PPT1, TPP1, CLN3, CLN5, CLN6, and CLN8 is their subcellular localization. To date, three of the four proteins whose subcellular localization has been confirmed, namely PPT1, TPP1, and CLN3, reside in the lysosome. We review the function of the CLN-proteins and discuss the possibility that a disruption in a common biological process leads to an NCL-disease.
This is a preview of subscription content, access via your institution.
References
Banerjee P., Dasgupta A., Siakotas A., and Dawson G. (1992) Evidence for lipase abnormality: high levels of free and triacylglycerol forms of unsaturated fatty acids in neuronal ceroid-lipofuscinoses. Am. J. Med. Genet. 42, 549–554.
Bellizzi J. J., Widom J., Kemp C., Lu J-Y., Das A. K., Hofmann S. L., and Clardy J. (2000) The crystal structure of palmitoyl protein thioesterase 1 and the molecular basis of infantile neuronal ceroid lipofuscinosis. Proc. Natl. Acad. Sci. USA 97, 4573–4578.
Berkovic S. F., Carpenter S., Andermann F., Andermann E., and Wolfe L. S. (1988) Kufs’ disease: a critical reappraisal. Brain 111(Pt 1), 27–62.
Bronson R. T., Donahue L. R., Johnson K. R., Tanner A., Lane P. W., and Faust J. R. (1998) Neuronal ceroid lipofuscinosis (nclf), a new disorder of the mouse linked to chromosome 9. Am. J. Med. Genet. 77, 289–297.
Broom M. F. and Zhou C. (2001) Fine mapping of ovine ceroid lipofuscinosis confirms orthology with CLN6. Euro. J. Paediatr. Neurol. 5(Suppl A), 33–36.
Camp L. A. and Hofmann S. L. (1993) Purification and properties of a palmitoyl-protein thioesterase that cleaves palmitate from H-Ras. J. Biol. Chem. 268, 22566–22574.
Chattopadhyay S. and Pearce D. A. (2000) Neural and extraneural expression of the neuronal ceroid lipofuscinoses genes CLN1, CLN2, and CLN3: functional implications for CLN3. Mol. Genet. Metab. 71, 207–11.
Das A. K., Becerra C. H. R., Won Y., Lu J. Y., Siakotos A. N., Wisniewski K. E., and Hoffman S. L. (1998) Molecular genetics of palmitoyl-protein thioesterase deficiency in the US. J. Clin. Invest. 102, 361–370.
Das A. K., Lu J-Y., and Hofmann S. L. (2001) Biochemical analysis of mutations in palmitoyl-protein thioesterase causing infantile and late-onset forms of neuronal ceroid lipofuscinosis. Hum. Mol. Genet. 10, 1431–1439.
Dawson G. and Cho, S. (2000) Batten’s Disease: clues to neuronal protein catabolism in lysosomes. J. Neurosci. rosci. Res. 60, 133–140.
Goebel H. H., Mole S E., and Lake B. D. (eds.) (1999) The Neuronal Ceroid Lipofuscinoses (Batten Disease). IOS Press, Amsterdam, Netherlands.
Elleder M., Lake B. D., Goebel, H. H., Rapola J., Haltia M., and Carpenter S. (1999) Definitions of ultrastructural patterns found in NCL, in The Neuronal Ceroid Lipofuscinoses (Batten Disease) (Goebel H. H., Mole S. E., and Lake B. D., eds.), IOS Press, Amsterdam, Netherlands, pp. 5–15.
Ezaki J., Tanida I., Kanehagi N., and Kominami E. (1999) A lysosomal proteinase, the late infantile neuronal ceroid lipofuscinosis gene (CLN2) product, is essential for degradation of a hydrophobic protein, the subunit c ATP synthase. J. Neurochem. 72, 2573–2582.
Gao H., Boustany R-M. N., Espinola J. A., Cotman S. L., Srinidhi L., Antonellis K. A., et al. (2002) Murations in a novel CLN6-encoded transmembrane protein cause Variant Neuronal Croid Lipofuscinosis in man and mouse. Am. J. Hum. Genet. 70, 324–335.
Gupta P., Soyombo A. A., Atashband A., Wisniewski K. E., Shelton J. M., Richardson J. A., et al. (2001) Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice. Proc. Natl. Acad. Sci. USA 98, 13566–13571.
Haines J. L., Boustany R. M., Alroy J., Auger K. J., Shook K. S., Terwedow H., and Lerner T. J. (1998) Chromosomal localization of two genes underlying late-infantile neuronal ceroid lipofuscinosis. Neurogenetic 1, 217–222.
Haltia M., Tyynela J., Hivasniemi A., Herva R., Ranta U. S., and Lehesjoki A. E. (1999) CLN8 - Northern epilepsy, in The Neuronal Ceroid Lipofuscinoses (Batten Disease) (Goebel H. H., Mole S. E., and Lake B. D., eds.), IOS Press, Amsterdam, Netherlands, pp. 117–124.
Haskell R. E., Carr C. J., Pearce D. A., Bennett M. J., and Davidson B. L. (2000) Batten disease: evaluation of CLN3 mutations on protein localization and function. Hum. Mol. Genet. 9, 735–744.
Haskell R. E., Derksen T. A., and Davidson B. L. (1999) Intracellular trafficking of the JNCL protein CLN3. Mol. Genet. Metab. 66, 253–260.
Heinonen O., Salonen T., Jalanko A., Peltonen L., and Copp A. (2000) CLN1 and CLN5, genes from infantile and variant late infantile neuronal ceroid lipofuscinoses, are expressed in the embryonic human brain. J. Comp. Neurol. 426, 406–412.
Hoffman S. L., Lee L. A., Lu J. Y., and Verkruyse L. A. (1997) Palmitoyl-protein thioesterase and the molecular pathogenesis of infantile neuronal ceroid lipofuscinosis. Neuropediatrics 28, 27–30.
Hofman I., Kohlschutter A., Santavuori P., Gottlob I., Goebel H. H., Lake B. D., et al. (1999) CLN3: Juvenile NCL, in The Neuronal Ceroid Lipofuscinoses (Batten Disease) (Goebel H. H., Mole S. E., and Lake B. D., eds.), IOS Press, Amsterdam, Netherlands, pp. 55–76.
International Batten Disease Consortium (1995) Isolation of a novel gene underlying Batten disease. Cell 82, 949–957.
Isosomppi J., Heinonen O., Hiltunen J. O., Greene, N. D. E., Vesa J., Uusitalo A., et al. (1999) Developmental expression of palmitoyl protein thioesterase in normal mice. Dev. Brain Res. 118, 1–11.
Jarvela I., Sainio M., Rantamaki T., Olkkonen V. M., Carpen O., Peltonen L., and Jalanko A. (1998) Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease. Hum. Mol. Genet. 7, 85–90.
Jarvela I., Lehtovirta M., Tikknen R., Kyttala A., and Jalanko A. (1998) Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL). Hum. Mol. Genet. 8, 1091–1098.
Junaid M. A., Wu G., and Pullarkat R. K. (2000) Purification and characterization of bovine brain lysosomal pepstatin-insensitive proteinase, the gene product deficient in the human late-infantile neuronal ceroid lipofuscinosis. J. Neurochem. 74, 287–294.
Kida E., Kaczmarski W., Golabek A. A., Kaczmarski A., Michalewskio M., and Wisnienski K. E. (1999) Analysis of intracellular distribution and trafficking of the CLN3 protein in fusion with the green fluorescent protein in vitro. Mol. Genet. Metab. 66, 265–271.
Kida E., Golabek A. A., Walus M., Wujek P., Kaczmarski W., and Wisniewski K. A. (2001) Distribution of Tripeptidyl Peptidase I in human tissues under normal and pathological conditions. J. Neuropathol. Exp. Neurol. 60, 280–292.
Kramer H. and Phistry M. (1999) Genetic analysis of hook, a gene required for endocytic trafficking in Drosophila. Genetics 151, 675–684
Kremmidiotis G., Lensink I. L., Bilton R. L., Woollatt E., Chataway T. K., Sutherland G. R., and Callen D. F. (1999) The Batten disease gene product (CLN3p) is a Golgi intergral membrane protein. Hum. Mol. Genet. 8, 523–531.
Lehtovirta M., Kyttala A., Eskelinen E. L., Hess M., Heinonen O., and Jalanko A. (2001) Palmitoyl protein thioesterase (PPT1) localizes into synaptosomes and synaptic vesicles in neurons: implications for infantile neuronal ceroid lipofuscinsis (INCL). Hum. Mol. Genet. 10, 69–75.
Lin L., Sohar I., Lackland H., and Lobel P. (2001) The human CLN2 protein/tripeptidyl-peptidase I is a serine protease that autoactivates at acidic pH. J. Biol. Chem. 276, 2249–2255.
Liu C. G., Sleat D. E., Donnelly R. J., and Lobel P. (1998) Structural organization and sequence of CLN2, the defective gene in classical late infantile neuronal ceroid lipofuscinosis. Genomics 50, 206–212.
Lonka L., Kyttala A., Jalanko A., and Lehesjoki A-E. (2000) The neuronal ceroid lipofusinosis CLN8 membrane protein is a resident of the endoplasmis reticulum. Hum. Mol. Genet. 11, 1691–1697.
Lu J-Y., Verkruyse L. A., and Hofmann L. (1996) Lipid thioesterase derived from acylate proteins accumulate in late infantile neuronal ceroid lipofuscinosis: correction of the defect in lymphoblasts by recombinate palmitoyl-protein thioesterase. Proc. Natl. Acad. Sci. USA 93, 10046–10050.
Martin J-J., Gottlob I., Goebel H. H., and Mole S. E. (1999) CLN4: Adult NCL, in The Neuronal Ceroid Lipofuscinoses (Batten Disease) (Goebel H. H., Mole S. E., and Lake B. D., eds.), IOS Press, Amsterdam, Netherlands, pp. 77–90.
Mitchell W. A., Wheeler R. B., Sharp J. D., Bate S. L., Gardiner R. M., Ranta U. S., et al. (2001) Turkish variant late infantile neuronal ceroid lipofuscinosis (CLN7) may be allelic to CLN8. Eur. J. Paediatr. Neurol. 5(Suppl. A), 21–27.
Mole S. E. (1998) Batten disease: four genes and still counting. Neurobiol. Dis. 5, 287–303.
Mole S. E., Mitchison H. M., and Munroe P. B. (1999) Molecular basis of the neuronal ceroid lipofuscinoses: Mutations in CLN1, CLN2, CLN3 and CLN5. Hum. Mutat. 14, 199–215.
Pearce D. A., Ferea T., Nosel S. A., Das B., and Sherman F. (1999) Action of BTN1, the yeast orthologue of the gene mutated in Batten disease. Nat. Genet. 22, 55–58.
Pearce D. A. and Sherman F. (1998) A yeast model for the study of Batten disease. Proc. Natl. Acad. Sci. USA 95, 6915–6918.
Pearce D. A. (2000) Localization and processing of CLN3, the protein associated to Batten disease: where is it and what does it do? J. Neurosci. Res. 59, 19–23.
Piper P. W., Ortiz-Calderon C., Holyoak C., Coote P., and Cole M. (1997) Hsp30, the integral plasma membrane heat shock protein of Saccharomyces cerevisiae, is a stress-inducible regulator of plasma membrane H+-ATPase. Cell Stress Chaper. 2, 12–24.
Ranta S., Savukoaki M., Santavuori P., and Haltia M. (2001) Studies of homogenous polulations: CLN5 and CLN8, in Batten Disease: Diagnosis, Treatment, and Research (Wisniewski K. E. and Zhong E., eds.), Academic Press, San Diego, CA, pp. 123–140.
Santavuori P., Rapola J., Nuutila A., Raininko R., Lappi M., Launes J., et al. (1991) The spectrum of Jansky-Bielschowsky Disease. Neuropediatrics 22, 92–96.
Santavori P., Rapola J., Rapola, J., Haltia, M., Tyynela, J., Peltonene, L., and Mole S. E. (1999) CLN5 - Finnish Variant Late Infantile NCL, in The Neuronal Ceroid Lipofuscinoses (Batten Disease) (Goebel H. H., Mole S. E., and Lake B. D., eds.), IOS Press, Amsterdam, Netherlands, pp. 91–101.
Savukoski M., Klockars T., Homberg V., Santavuori P., Lander E. S., and Peltonen L. (1998) CLN5, a novel gene encoding a putative transmembrane protein mutated in Finnish variant late infantile neuronal ceroid lipofuscinosis. Nat. Genet. 19, 286–288
Sharp J. D. (1997) Loci for classical and a variant late infantile neuronal ceroid liposfuscinosis map to chromosomes 11p15 and 15q21–23. Hum. Mol. Genet. 6, 591–595.
Sleat D. E., Donnelly R. J., Lackland H., Liu C. G., Sohar I., Pullarkat R. K., and Lobel P. (1997) Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis. Science 277, 1802–1805.
Sleat D. E., Gin R. M., Sohar I., Wisniewski K., Sklower-Brooks S., Pullarkat R. K., et al. (1999) Mutational analysis of the defective protease in classic late-infantile neuronal ceroid lipofuscinosis, a neurodegnerative lysosomal storage disorder. Am. J. Hum. Genet. 64, 1511–1523.
Sohar I., Sleat D. E., Jadot M., and Lobel P. (1999) Biochemical characterization of a lysosomal protease deficient in classical late infantile neuronal ceroid lipofuscinosis (LINCL) and development of an enzyme-based assay for diagnosis and exclusion of LINCL in human specimens and animal models. J. Neurochem. 73, 700–711.
Sunio A., Metcalf A. B., and Kramer H. (1999) Genetic dissection of endocytic trafficking in Drosophila using a horseradish peroxidase-bride of sevenless chimera: hook is required for normal maturation of multivesicular endosomes. Mol. Biol. Cell. 10, 847–859.
Suopanki J., Tyynela J., Baumann M., and Haltia M. (1999) Palmitoyl-protein thioesterase, an enzyme implicated in neurodegeneration, is localized in neurons and is developmentally regulated in rat brain. Neurosci. Lett. 265, 53–56.
Tahvanainen E., Ranta S., Hirvasniemi A., Karila E., Leisti J., Sistonen P., et al. (1994) The gene for a recessively inherited human childhood progressive epilepsy with mental retardation maps to the distal short arm of chromosome 8. Proc. Natl. Acad. Sci. USA 91, 7267–70.
Tammen I., Cook R. W., Nicholas F. W., and Raadsma H. W. (2001) Neuronal ceroid lipofuscinosis in Australian Merino sheep: a new animal model. Euro. J. Paediatr. Neurol. 5(Suppl A), 37–41.
Tomkinson B. (1999) Tripeptidyl peptidases: Enzymes that count. Trends Biochem. Sci. 24, 355–359.
van Diggelen O. P., Thobois S., Tilikete C., Zabot M-T., Keuleman J. L. M., van Bunderen P. A., et al. (2001) Adult Neuronal ceroid lipofusinosis with palmitoyl-protein thioesterase deficiency: First adult-onset patients of a childhood disease. Ann. Neurol. 50, 269–272.
Verkruyse L. A. and Hoffman S. L. (1996) Lysosomal targeting of palmitoyl-protein thioesterase. J. Biol. Chem. 271, 15831–15836.
Vines D. and Warburton M. J. (1998) Purification and characterization of tripeptidyl aminopeptidase I from rat spleen. Biochem. Biophys. Acta 1384, 233–242.
Wheeler R. B., Sharp J. D., Schultz R. A., Joslin J. M., Williams R. E., and Mole S. E. (2002) The gene mutated in variant Late-Infantile Neuronal Ceroid Lipofuscinosis (CLN6) and in nclf mutant mice encodes a novel predicted transmembrane protein. Am. J. Hum. Genet. 70, 537–542.
Williams R. E., Gottlob I., Lake B. D., Goebel H. H., Winchester, B. G., and Wheeler, R. B. (1999) CLN2-Classic Late Infantile NCL, in The Neuronal Ceroid Lipofuscinoses (Batten Disease) (Goebel H. H., Mole S. E., and Lake B. D., eds.), IOS Press, Amsterdam, Netherlands, pp. 37–54.
Williams R. E., Topcu M., Lake B. D., Mitchell W., and Mole S. E. (1999) CLN7-Turkish variant Late Infantile NCL, in The Neuronal Ceroid Lipofuscinoses (Batten Disease) (Goebel H. H., Mole S. E., and Lake B. D., eds.), IOS Press, Amsterdam, Netherlands, pp. 114–116.
Wisniewski K. E., Kaczmarski A., Kida E., Connell F., Kaczmarski W., Michalewski M. P., et al. (1999) Reevaluation of neuronal ceroid lipofuscinosis: atypical juvenile onset may be the result of CLN2 mutations. Mol. Genet. Metab. 66, 248–252.
Author information
Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Weimer, J.M., Kriscenski-Perry, E., Elshatory, Y. et al. The neuronal ceroid lipofuscinoses. Neuromol Med 1, 111–124 (2002). https://doi.org/10.1385/NMM:1:2:111
Received:
Accepted:
Issue Date:
Index Entries
- Neuronal Ceroid Lipofuscinoses
- Batten disease
- lysosome
- protein trafficking
- neurodegeneration